The short-acting insulin market is estimated to be valued at USD 10.00 Bn in 2025 and is expected to reach USD 14.35 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032. https://coherentmi01.livepositively.com/short-acting-insulin-market-emerging-trends-driving-significant-market-growth/new=1